MARKET

SPRB

SPRB

Spruce Biosciences, Inc.
NASDAQ
0.3190
-0.0040
-1.24%
Closed 16:00 03/26 EDT
OPEN
0.3200
PREV CLOSE
0.3230
HIGH
0.3299
LOW
0.3044
VOLUME
110.55K
TURNOVER
--
52 WEEK HIGH
0.8700
52 WEEK LOW
0.3044
MARKET CAP
13.18M
P/E (TTM)
-0.3324
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SPRB last week (0317-0321)?
Weekly Report · 2d ago
Spruce Biosciences Inc <SPRB.OQ> expected to post a loss of 21 cents a share - Earnings Preview
Reuters · 5d ago
Weekly Report: what happened at SPRB last week (0310-0314)?
Weekly Report · 03/17 09:19
Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates
NASDAQ · 03/11 12:40
Weekly Report: what happened at SPRB last week (0303-0307)?
Weekly Report · 03/10 09:19
Spruce Biosciences Inc <SPRB.OQ> expected to post a loss of 21 cents a share - Earnings Preview
Reuters · 03/07 11:12
Weekly Report: what happened at SPRB last week (0224-0228)?
Weekly Report · 03/03 09:19
Weekly Report: what happened at SPRB last week (0217-0221)?
Weekly Report · 02/24 09:19
More
About SPRB
More
Spruce Biosciences, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing therapies for rare endocrine disorders with significant unmet medical needs. The Company is initially developing its wholly owned product candidate, Tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). It is also developing Tildacerfont for females suffering from polycystic ovary syndrome (PCOS). It has initiated CAHmelia-203, a placebo-controlled, double-blind Phase IIb clinical trial in adult patients with classic CAH with elevated levels of androstenedione (A4) at baseline. It has also initiated CAHmelia-204, a second Phase IIb clinical trial in adult patients with classic CAH on supraphysiologic doses of glucocorticoids with normal or near normal levels of A4 at baseline focused on glucocorticoid reduction. The Company also investigates tildacerfont for the treatment of classic CAH in children.
Recently
Symbol
Price
%Change

Webull offers Spruce Biosciences Inc stock information, including NASDAQ: SPRB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPRB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPRB stock methods without spending real money on the virtual paper trading platform.